Dr Robert John Thorsness, MD | |
951 Essington Rd, Joliet, IL 60435-8427 | |
(815) 744-4455 | |
(815) 744-4756 |
Full Name | Dr Robert John Thorsness |
---|---|
Gender | Male |
Speciality | Orthopedic Surgery |
Experience | 14 Years |
Location | 951 Essington Rd, Joliet, Illinois |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1588989164 | NPI | - | NPPES |
036137168 | Other | IL | IL MD LICENSE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | 036137168 (Illinois) | Secondary |
207XS0106X | Orthopaedic Surgery - Hand Surgery | 036137168 (Illinois) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Peak Home Health Care, Llc | Joliet, IL | Home health agency |
Silver Cross Hospital And Medical Centers | New lenox, IL | Hospital |
Adventist La Grange Memorial Hospital | La grange, IL | Hospital |
Presence Saint Joseph Medical Center | Joliet, IL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Illinois Bone And Joint Institute Llc | 6002814878 | 519 |
News Archive
"Artificial water fluoridation prevalence was significantly positively associated with ADHD prevalence," according to research published in Environmental Health (2/15), reports the Fluoride Action Network (FAN).
Tuberculosis is one of the most widespread life-threatening infectious diseases. Not only does antibiotic resistance make treatment increasingly difficult, but the bacteria's relatively impermeable mycomembrane also limits the effectiveness of many drugs.
With the discovery of suitable molecular targets - cellular molecules along pathways crucial for sustaining the life of cancer cells - comes the perplexing dilemma of where to find the next therapeutics that will bind to and disable those targets.
International biopharmaceutical company Specialised Therapeutics Asia will supply and distribute a novel oncology drug candidate throughout South East Asia, following an exclusive licensing deal with European pharmaceutical company PharmaMar.
Mr. Brian Pedlar, President and CEO of Covalon Technologies Ltd., an advanced medical technologies company, is pleased to provide the following update. "We are very pleased that Covalon continues to make excellent progress in meeting its objectives.
› Verified 2 days ago
Entity Name | Hinsdale Orthopaedic Associates, S.c. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1235217209 PECOS PAC ID: 3476549452 Enrollment ID: O20040423001010 |
News Archive
"Artificial water fluoridation prevalence was significantly positively associated with ADHD prevalence," according to research published in Environmental Health (2/15), reports the Fluoride Action Network (FAN).
Tuberculosis is one of the most widespread life-threatening infectious diseases. Not only does antibiotic resistance make treatment increasingly difficult, but the bacteria's relatively impermeable mycomembrane also limits the effectiveness of many drugs.
With the discovery of suitable molecular targets - cellular molecules along pathways crucial for sustaining the life of cancer cells - comes the perplexing dilemma of where to find the next therapeutics that will bind to and disable those targets.
International biopharmaceutical company Specialised Therapeutics Asia will supply and distribute a novel oncology drug candidate throughout South East Asia, following an exclusive licensing deal with European pharmaceutical company PharmaMar.
Mr. Brian Pedlar, President and CEO of Covalon Technologies Ltd., an advanced medical technologies company, is pleased to provide the following update. "We are very pleased that Covalon continues to make excellent progress in meeting its objectives.
› Verified 2 days ago
Entity Name | Illinois Bone And Joint Institute Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1205922432 PECOS PAC ID: 6002814878 Enrollment ID: O20061110000331 |
News Archive
"Artificial water fluoridation prevalence was significantly positively associated with ADHD prevalence," according to research published in Environmental Health (2/15), reports the Fluoride Action Network (FAN).
Tuberculosis is one of the most widespread life-threatening infectious diseases. Not only does antibiotic resistance make treatment increasingly difficult, but the bacteria's relatively impermeable mycomembrane also limits the effectiveness of many drugs.
With the discovery of suitable molecular targets - cellular molecules along pathways crucial for sustaining the life of cancer cells - comes the perplexing dilemma of where to find the next therapeutics that will bind to and disable those targets.
International biopharmaceutical company Specialised Therapeutics Asia will supply and distribute a novel oncology drug candidate throughout South East Asia, following an exclusive licensing deal with European pharmaceutical company PharmaMar.
Mr. Brian Pedlar, President and CEO of Covalon Technologies Ltd., an advanced medical technologies company, is pleased to provide the following update. "We are very pleased that Covalon continues to make excellent progress in meeting its objectives.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Robert John Thorsness, MD 951 Essington Rd, Joliet, IL 60435-8427 Ph: (815) 744-4455 | Dr Robert John Thorsness, MD 951 Essington Rd, Joliet, IL 60435-8427 Ph: (815) 744-4455 |
News Archive
"Artificial water fluoridation prevalence was significantly positively associated with ADHD prevalence," according to research published in Environmental Health (2/15), reports the Fluoride Action Network (FAN).
Tuberculosis is one of the most widespread life-threatening infectious diseases. Not only does antibiotic resistance make treatment increasingly difficult, but the bacteria's relatively impermeable mycomembrane also limits the effectiveness of many drugs.
With the discovery of suitable molecular targets - cellular molecules along pathways crucial for sustaining the life of cancer cells - comes the perplexing dilemma of where to find the next therapeutics that will bind to and disable those targets.
International biopharmaceutical company Specialised Therapeutics Asia will supply and distribute a novel oncology drug candidate throughout South East Asia, following an exclusive licensing deal with European pharmaceutical company PharmaMar.
Mr. Brian Pedlar, President and CEO of Covalon Technologies Ltd., an advanced medical technologies company, is pleased to provide the following update. "We are very pleased that Covalon continues to make excellent progress in meeting its objectives.
› Verified 2 days ago
Jason Gregory Hurbanek, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 951 Essington Rd, Joliet, IL 60435 Phone: 815-744-4551 Fax: 815-744-4756 | |
Dr. Leah R Urbanosky, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 951 Essington Rd, Joliet, IL 60435 Phone: 815-744-4551 Fax: 815-744-4756 | |
Dr. Rebecca Chin Kuo, M. D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1445 Essington Rd., Joliet, IL 60435 Phone: 815-741-6900 Fax: 815-741-6907 | |
Jerry E Bertolini, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 202 N Hammes, Suite D, Joliet, IL 60435 Phone: 815-741-4104 Fax: 815-741-4135 | |
Nitin Goyal, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 963 N 129th Infantry Dr, Joliet, IL 60435 Phone: 877-632-6637 | |
Dr. Anuj S. Puppala, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 951 Essington Rd, Joliet, IL 60435 Phone: 815-744-4551 Fax: 815-744-4756 |